Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
36,36 USD | +1,54 % | -2,26 % | +31,93 % |
Resumen de negocios
Número de empleados: 1 022
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Small Molecule and Gene Therapeutics
100,0
%
| 699 | 100,0 % | 938 | 100,0 % | +34,20 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
56,7
%
| 499 | 71,3 % | 532 | 56,7 % | +6,64 % |
Non-United States
43,3
%
| 200 | 28,7 % | 406 | 43,3 % | +102,84 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Matthew Klein
CEO | Chief Executive Officer | 52 | 01/10/19 |
Pierre Gravier
DFI | Director of Finance/CFO | 39 | 13/07/23 |
Ellen Welch
CTO | Chief Tech/Sci/R&D Officer | - | - |
Neil Almstead
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/01/00 |
Kylie O'Keefe
IRC | Investor Relations Contact | - | 01/05/18 |
Human Resources Officer | - | 01/01/18 | |
Marla Weetall
PRN | Corporate Officer/Principal | - | 01/10/02 |
Corporate Officer/Principal | - | - | |
Christine Utter
AUD | Comptroller/Controller/Auditor | 46 | 01/01/10 |
Murad Husain
PRN | Corporate Officer/Principal | - | 29/01/14 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Glenn Steele
BRD | Director/Board Member | 79 | 15/06/15 |
Chairman | 72 | 01/08/01 | |
David Southwell
BRD | Director/Board Member | 63 | 01/12/05 |
Allan Jacobson
FOU | Founder | 78 | 31/03/98 |
Emma Reeve
BRD | Director/Board Member | 63 | 18/12/18 |
Jerome Zeldis
BRD | Director/Board Member | 74 | 28/09/12 |
Alethia Young
BRD | Director/Board Member | 45 | 09/06/22 |
Matthew Klein
CEO | Chief Executive Officer | 52 | 01/10/19 |
Mary Smith
BRD | Director/Board Member | 61 | 08/06/21 |
Stephanie Okey
BRD | Director/Board Member | 64 | 18/12/18 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 76 696 785 | 74 841 517 ( 97,58 %) | 0 | 97,58 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
CLEARPOINT NEURO, INC. 3.32% | 894 578 | 3.32% | 4 750 209 $ |
Información de la empresa
PTC Therapeutics, Inc.
500 Warren Corporate Center Drive
07059, Warren
+908 222 7000
http://www.ptcbio.comEmpresas del grupo
Nombre | Categoría y sector |
---|---|
PTC Therapeutics International Ltd.
|
Sector
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+31,93 % | 2788,7 M | |
+11,60 % | 106 mil M | |
-4,68 % | 24,28 mil M | |
-0,82 % | 21,96 mil M | |
-10,12 % | 18,16 mil M | |
-42,12 % | 16,37 mil M | |
-17,47 % | 15,56 mil M | |
+2,77 % | 13,63 mil M | |
+34,58 % | 12,27 mil M | |
+77,64 % | 8873,08 M |
- Bolsa de valores
- Acciones
- Acción PTCT
- Empresa PTC Therapeutics, Inc.